Recent advances in the genetics of sarcoidosis

@article{Spagnolo2013RecentAI,
  title={Recent advances in the genetics of sarcoidosis},
  author={Paolo Spagnolo and Johan Grunewald},
  journal={Journal of Medical Genetics},
  year={2013},
  volume={50},
  pages={290 - 297}
}
Sarcoidosis is a heterogeneous inflammatory disorder of unknown origin that may affect virtually any organ, although intrathoracic engagement is almost universal. Sarcoidosis may present rather dramatically as an acute disease, which usually resolves either spontaneously or with treatment, while other patients have an insidious onset and a chronic/progressive disease course. The different clinical phenotypes have led to the suggestion that sarcoidosis may consist of several separate entities… Expand
Immunogenetics of Disease-Causing Inflammation in Sarcoidosis
TLDR
The aetiology of sarcoidosis remains elusive and its pathogenesis incompletely understood, and there is an urgent need for a better understanding of disease pathogenesis, which hopefully will translate into the development of truly effective therapies. Expand
Sarcoidosis: a Critical Review of History and Milestones
  • P. Spagnolo
  • Medicine
  • Clinical Reviews in Allergy & Immunology
  • 2015
Sarcoidosis is a chronic systemic disease of unknown origin and uncertain prognosis that most commonly affects young adults, and frequently presents with bilateral hilar lymphadenopathy, pulmonaryExpand
Selected molecular events in the pathogenesis of sarcoidosis - recent advances.
TLDR
The role of both TGF-b/Smad and (HIF)-1a-VEGF-ING-4 signaling pathways in the development of sarcoidosis is elucidated, and the potential epigenetic regulation of the processes occurring in sarCOidosis by miRNA is discussed. Expand
Studies of different clinical manifestations of Sarcoidosis and the role of genetic factors
TLDR
The HLA-DRB1*04 allele is associated with an increased risk for involvement of the eyes, parotid and/or salivary glands and cranial nerves in sarcoidosis patients, and an increased CD4/CD8-ratio in enlarged LNs is not diagnostic for sarCOidosis in comparison to BALF, which indicates an airborne antigen as the triggering factor. Expand
Pulmonary Manifestations of Sarcoidosis
TLDR
It does not appear that early treatment substantially influences the likelihood of spontaneous remission, and the indications for treatment fall broadly into the two categories of threats to organ function and significant impairment of the quality of life. Expand
Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin?
TLDR
Molecular mimicry may be seen as the main pathogenic generator not only of Sarcoidosis but also of sarcoid-like reactions, which may in turn allow for a more appropriate therapy and improvement in the quality of life of the patients. Expand
Sarcoidosis: Immunopathogenesis and Immunological Markers
TLDR
The immunological features of sarcoidosis are outlined, the evidence for and against various candidate etiological agents (infective and noninfective), the exhaled breath condensate is described, and a novel method of identifying immunological biomarkers is described to better characterise the immunopathogenesis of sarCOidosis. Expand
Sarcoidosis: a state of the art review from the Thoracic Society of Australia and New Zealand
TLDR
The current understanding of sarcoidosis is outlined, and whole body positron emission tomography scanning has improved localisation of disease, but no single biomarker is adequately sensitive and specific for detecting and monitoring disease activity. Expand
Immunogenetics of Sarcoidosis
TLDR
To understand the sarcoidosis susceptibility at genetic level, several molecular approaches, such as meta-analysis of GWAS, significant association of coding and rare variants, fine mapping of susceptible loci, gene networking and their associated mechanism, copy number variations, single nucleotide polymorphisms in miRNAs (mirSNPs) and epigenetic changes in case control studies across cohorts of different ethnic groups would reveal a better insight. Expand
Current opinion on the pathogenesis of sarcoidosis involves sequence of immunological reactions leading to granuloma formation. These events involve internalization of the foreign antigen(s), its further processing and presentation by antigen presenting cells (APCs) such as dendritic cells or macrop
Sarcoidosis is a multi-facets disease. Along with environment, the role of genetic component in this immune-mediated granulomatous disorder is undisputable, irrespective of the tissue/ organ involvedExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 122 REFERENCES
Sarcoidosis: challenging diagnostic aspects of an old disease.
TLDR
It is strongly advised that physicians be ready to reconsider the diagnosis of sarcoidosis in the presence of atypical manifestations or persistent/progressive disease despite conventional therapy. Expand
Review: role of genetics in susceptibility and outcome of sarcoidosis.
  • J. Grunewald
  • Biology, Medicine
  • Seminars in respiratory and critical care medicine
  • 2010
TLDR
The well studied associations between sarcoidosis and HLA-class II molecules indicate specific antigen presentation for T helper cells, which is in agreement with the characteristic finding of lung-accumulated CD4+ T helpers cells expressing a limited set of T cell receptors. Expand
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases.
TLDR
Evidence for an individual predisposition to develop pulmonary granulomatous diseases of unknown origin is reported, specifically sarcoidosis, Blau syndrome, and systemic vasculitides, suggesting that stratification of data by clinical phenotypes may discover genetic associations that analysis of disease susceptibility alone would fail to detect. Expand
BTNL2 gene variant and sarcoidosis
TLDR
Familial clustering of the disease and the increased risk of relatives to develop sarcoidosis suggest that there might be a genetic predisposition to develop the disease. Expand
Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?
TLDR
Immunological, bacteriological and genetic data support a link between CD and sarcoidosis, and the concept of a genetic component is supported by disease being more common in monozygotic twins compared with dizygotic twins. Expand
First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis
TLDR
A genetic association between sarcoidosis and a truncating splice-site mutation in the gene BTNL2 (butyrophilin-like 2, a member of the immunoglobulin gene family) has been confirmed in different studies and populations. Expand
Genetics of sarcoidosis.
TLDR
The exploration of the molecular epidemiology of genetic variants in the pathogenesis of sarcoidosis will allow an assessment of their prognostic usefulness and a useful route for clinical translation. Expand
A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1.
TLDR
This study provides striking evidence for association of chromosome 11q13.1 with sarcoidosis in Europeans, and thus identified a further genetic risk locus shared by sarcoidsosis, Crohn disease and psoriasis. Expand
Genetics of Sarcoidosis.
TLDR
The HLA region is the most strongly and consistently associated genetic risk factor for sarcoidosis, supporting the notion that sarcoIDosis is an exposure-mediated immunologic disease. Expand
Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes
TLDR
The finding that the nonsynonymous SNP rs11209026 in the interleukin (IL)-23 receptor (IL23R) gene was associated with chronic sarcoidosis highlights the potential importance of the IL-23 signalling pathway for the development of chronic sarCOidosis. Expand
...
1
2
3
4
5
...